Nuvonis Technologies
Nuvonis Technologies
Facts
- Founded
- 2016
- Staff
- 8
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
-
agricultural biotechnology
human health / animal health
animal health - Topic
- Other
- Focus R&D
-
development
applied research - Research area
-
biological sciences
agricultural biotechnology
medical and health sciences
veterinary medicine
industrial biotechnology - Offer
- design- und production consulting
- Focus
- consumables / reagents
Profile
Nuvonis is a biotech company providing ready to use cell banks for vaccine and vector production. In addition, Nuvonis' experienced team provides technical support for virus production processes and vaccine strain improvement. GMP cell banks available (fully tested to ICH guidelines, serum/animal component free):
# suspension quail cells CCX.E10
# adherent quail cells CCX.2C4
# Vero cells
# suspension chicken GGF24 cells
R&D:Our proprietary CCX quail and GGF24 chicken cell lines are designed to replace primary chicken cells, providing an efficient platform for the production of a broad range of viral vaccines and vectors, including different strains of attenuated viruses and vectors such as NDV, VSV and MVA. These cell lines are licensed to numerous international clients in the human and veterinary vaccine industries. Our GMP Vero cell banks allow fast transition into clinical production and clinical trials. All Nuvonis cell lines are available as R&D cells or as fully tested GMP cells, cultivated in anomal component free medium that is commercially available
Production:Our GMP cell banks were produced by qualified external partners, and all quality tests according to guidelines and release was performed.
Services:Based on our long experience in vaccine manufacturing and process development, we optimize and implement upstream production methods using a variety of systems (T-flasks, spinner culture, cell stacks, bioreactors and high-density bioreactor systems) on a lab scale. This includes the establishment of accurate and fast titer assays enabling efficient process optimization.
Sales/Distribution:Our GMP cell banks (Vero, avian CCX cell line and chicken GGF24 cells) are sold based on flexible conditions for research or commercial use.
Similar companies in RDM biotech/pharma
Tridem Bioscience Gmbh und CoKG
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- human health
Institut Allergosan Pharmazeutische Produkte
- Organization type
- RDM biotech/pharma
- Region
- Styria
- Cluster
- Human.technology Styria
Polymun Scientific Immunbiologische Forschung GmbH
- Organization type
- RDM biotech/pharma
- Region
- Lower Austria
- Cluster
- ecoplus
- Focus
- non-specific applications
Kwizda Pharma
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
Contact
Mariahilfer Straße 101/1/21
Vienna
Vienna
Contact: Joachim Seipelt
Telephone: 4369912350457
Email: office@nuvonis.com
Website